543 related articles for article (PubMed ID: 26906225)
1. Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis.
Valentin-Torres A; Savarin C; Hinton DR; Phares TW; Bergmann CC; Stohlman SA
J Neuroinflammation; 2016 Feb; 13():46. PubMed ID: 26906225
[TBL] [Abstract][Full Text] [Related]
2. Blockade of sustained tumor necrosis factor in a transgenic model of progressive autoimmune encephalomyelitis limits oligodendrocyte apoptosis and promotes oligodendrocyte maturation.
Valentin-Torres A; Savarin C; Barnett J; Bergmann CC
J Neuroinflammation; 2018 Apr; 15(1):121. PubMed ID: 29690885
[TBL] [Abstract][Full Text] [Related]
3. An IFNγ/CXCL2 regulatory pathway determines lesion localization during EAE.
Stoolman JS; Duncker PC; Huber AK; Giles DA; Washnock-Schmid JM; Soulika AM; Segal BM
J Neuroinflammation; 2018 Jul; 15(1):208. PubMed ID: 30012158
[TBL] [Abstract][Full Text] [Related]
4. Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model.
Mills Ko E; Ma JH; Guo F; Miers L; Lee E; Bannerman P; Burns T; Ko D; Sohn J; Soulika AM; Pleasure D
J Neuroinflammation; 2014 Jun; 11():105. PubMed ID: 24924222
[TBL] [Abstract][Full Text] [Related]
5. Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.
Savarin C; Hinton DR; Valentin-Torres A; Chen Z; Trapp BD; Bergmann CC; Stohlman SA
J Neuroinflammation; 2015 Apr; 12():79. PubMed ID: 25896970
[TBL] [Abstract][Full Text] [Related]
6. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
[TBL] [Abstract][Full Text] [Related]
7. Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE.
Moreno M; Bannerman P; Ma J; Guo F; Miers L; Soulika AM; Pleasure D
J Neurosci; 2014 Jun; 34(24):8175-85. PubMed ID: 24920622
[TBL] [Abstract][Full Text] [Related]
8. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Juedes AE; Hjelmström P; Bergman CM; Neild AL; Ruddle NH
J Immunol; 2000 Jan; 164(1):419-26. PubMed ID: 10605038
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms.
Moransard M; Bednar M; Frei K; Gassmann M; Ogunshola OO
J Neuroinflammation; 2017 Oct; 14(1):202. PubMed ID: 29029628
[TBL] [Abstract][Full Text] [Related]
10. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
[TBL] [Abstract][Full Text] [Related]
11. Expression of the HGF receptor c-met by macrophages in experimental autoimmune encephalomyelitis.
Moransard M; Sawitzky M; Fontana A; Suter T
Glia; 2010 Apr; 58(5):559-71. PubMed ID: 19941340
[TBL] [Abstract][Full Text] [Related]
12. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.
Lee E; Chanamara S; Pleasure D; Soulika AM
J Neuroinflammation; 2012 Jan; 9():7. PubMed ID: 22248039
[TBL] [Abstract][Full Text] [Related]
13. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
[TBL] [Abstract][Full Text] [Related]
14. Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination.
Brambilla R; Morton PD; Ashbaugh JJ; Karmally S; Lambertsen KL; Bethea JR
Glia; 2014 Mar; 62(3):452-67. PubMed ID: 24357067
[TBL] [Abstract][Full Text] [Related]
15. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE.
Bennett J; Basivireddy J; Kollar A; Biron KE; Reickmann P; Jefferies WA; McQuaid S
J Neuroimmunol; 2010 Dec; 229(1-2):180-91. PubMed ID: 20832870
[TBL] [Abstract][Full Text] [Related]
16. Regulatory role of oligodendrocyte gap junctions in inflammatory demyelination.
Papaneophytou CP; Georgiou E; Karaiskos C; Sargiannidou I; Markoullis K; Freidin MM; Abrams CK; Kleopa KA
Glia; 2018 Dec; 66(12):2589-2603. PubMed ID: 30325069
[TBL] [Abstract][Full Text] [Related]
17. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
[TBL] [Abstract][Full Text] [Related]
18. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
[TBL] [Abstract][Full Text] [Related]
19. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling.
Zhang D; Qiao L; Fu T
Biomed Pharmacother; 2020 May; 125():109528. PubMed ID: 32106388
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic proteins 4, 6, and 7 are up-regulated in mouse spinal cord during experimental autoimmune encephalomyelitis.
Ara J; See J; Mamontov P; Hahn A; Bannerman P; Pleasure D; Grinspan JB
J Neurosci Res; 2008 Jan; 86(1):125-35. PubMed ID: 17722066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
